175 related articles for article (PubMed ID: 38043981)
1. Gene therapy for neurodegenerative disorders in children: dreams and realities.
Boespflug-Tanguy O; Sevin C; Piguet F
Arch Pediatr; 2023 Nov; 30(8S1):8S32-8S40. PubMed ID: 38043981
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for leukodystrophies.
Biffi A; Aubourg P; Cartier N
Hum Mol Genet; 2011 Apr; 20(R1):R42-53. PubMed ID: 21459776
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
Fumagalli F; Calbi V; Natali Sora MG; Sessa M; Baldoli C; Rancoita PMV; Ciotti F; Sarzana M; Fraschini M; Zambon AA; Acquati S; Redaelli D; Attanasio V; Miglietta S; De Mattia F; Barzaghi F; Ferrua F; Migliavacca M; Tucci F; Gallo V; Del Carro U; Canale S; Spiga I; Lorioli L; Recupero S; Fratini ES; Morena F; Silvani P; Calvi MR; Facchini M; Locatelli S; Corti A; Zancan S; Antonioli G; Farinelli G; Gabaldo M; Garcia-Segovia J; Schwab LC; Downey GF; Filippi M; Cicalese MP; Martino S; Di Serio C; Ciceri F; Bernardo ME; Naldini L; Biffi A; Aiuti A
Lancet; 2022 Jan; 399(10322):372-383. PubMed ID: 35065785
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.
Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Bougnères P; Schmidt M; Kalle CV; Fischer A; Cavazzana-Calvo M; Aubourg P
Methods Enzymol; 2012; 507():187-98. PubMed ID: 22365775
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.
Biffi A; Montini E; Lorioli L; Cesani M; Fumagalli F; Plati T; Baldoli C; Martino S; Calabria A; Canale S; Benedicenti F; Vallanti G; Biasco L; Leo S; Kabbara N; Zanetti G; Rizzo WB; Mehta NA; Cicalese MP; Casiraghi M; Boelens JJ; Del Carro U; Dow DJ; Schmidt M; Assanelli A; Neduva V; Di Serio C; Stupka E; Gardner J; von Kalle C; Bordignon C; Ciceri F; Rovelli A; Roncarolo MG; Aiuti A; Sessa M; Naldini L
Science; 2013 Aug; 341(6148):1233158. PubMed ID: 23845948
[TBL] [Abstract][Full Text] [Related]
8. Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells.
Biffi A; De Palma M; Quattrini A; Del Carro U; Amadio S; Visigalli I; Sessa M; Fasano S; Brambilla R; Marchesini S; Bordignon C; Naldini L
J Clin Invest; 2004 Apr; 113(8):1118-29. PubMed ID: 15085191
[TBL] [Abstract][Full Text] [Related]
9. [Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector].
Cartier N; Hacein-Bey-Abina S; Von Kalle C; Bougnères P; Fischer A; Cavazzana-Calvo M; Aubourg P
Bull Acad Natl Med; 2010 Feb; 194(2):255-64; discussion 264-8. PubMed ID: 21166117
[TBL] [Abstract][Full Text] [Related]
10. An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.
Ashrafi MR; Amanat M; Garshasbi M; Kameli R; Nilipour Y; Heidari M; Rezaei Z; Tavasoli AR
Expert Rev Neurother; 2020 Jan; 20(1):65-84. PubMed ID: 31829048
[No Abstract] [Full Text] [Related]
11. Recent Advancements in the Diagnosis and Treatment of Leukodystrophies.
Bradbury AM; Ream MA
Semin Pediatr Neurol; 2021 Apr; 37():100876. PubMed ID: 33892849
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in hematopoietic gene therapy for genetic disorders.
Galy A; Dewannieux M
Arch Pediatr; 2023 Nov; 30(8S1):8S24-8S31. PubMed ID: 38043980
[TBL] [Abstract][Full Text] [Related]
13. Gene and Cellular Therapies for Leukodystrophies.
Aerts-Kaya F; van Til NP
Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004502
[TBL] [Abstract][Full Text] [Related]
14. Developing therapeutic approaches for metachromatic leukodystrophy.
Patil SA; Maegawa GH
Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
[TBL] [Abstract][Full Text] [Related]
15. Safety of Direct Intraparenchymal AAVrh.10-Mediated Central Nervous System Gene Therapy for Metachromatic Leukodystrophy.
Rosenberg JB; Chen A; De BP; Dyke JP; Ballon DJ; Monette S; Ricart Arbona RJ; Kaminsky SM; Crystal RG; Sondhi D
Hum Gene Ther; 2021 Jun; 32(11-12):563-580. PubMed ID: 33380277
[TBL] [Abstract][Full Text] [Related]
16. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
[TBL] [Abstract][Full Text] [Related]
17. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
Eichler F; Duncan C; Musolino PL; Orchard PJ; De Oliveira S; Thrasher AJ; Armant M; Dansereau C; Lund TC; Miller WP; Raymond GV; Sankar R; Shah AJ; Sevin C; Gaspar HB; Gissen P; Amartino H; Bratkovic D; Smith NJC; Paker AM; Shamir E; O'Meara T; Davidson D; Aubourg P; Williams DA
N Engl J Med; 2017 Oct; 377(17):1630-1638. PubMed ID: 28976817
[TBL] [Abstract][Full Text] [Related]
19. Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models.
Lattanzi A; Neri M; Maderna C; di Girolamo I; Martino S; Orlacchio A; Amendola M; Naldini L; Gritti A
Hum Mol Genet; 2010 Jun; 19(11):2208-27. PubMed ID: 20203170
[TBL] [Abstract][Full Text] [Related]
20. Atidarsagene autotemcel for metachromatic leukodystrophy.
Messina M; Gissen P
Drugs Today (Barc); 2023 Feb; 59(2):63-70. PubMed ID: 36811406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
